title: The impact of coronary artery disease on the coronary vasomotor response to nonionic contrast media.
abstract: BACKGROUND
  Coronary artery disease (CAD) alters the vasomotor response to a variety of pharmacological agents. We tested the hypothesis that CAD also has an impact on the coronary vasomotor response to radiologic contrast media.
  
  
  RESULTS
  We performed quantitative coronary angiography in 42 patients without angiographic evidence of CAD and 38 patients with CAD in the left coronary artery. Angiographically smooth coronary segments (n=235) were analyzed for changes on luminal diameters and coronary venous oxygen saturation in response to 3 media: the nonionic dimer iodixanol, the nonionic monomer iopromide, and the ionic agent ioxaglate. In subjects without CAD, we assessed the effects of intracoronary administration of the nitric oxide synthase inhibitor N(G)-monomethyl-L-arginine and of the cyclooxygenase inhibitor indomethacin on such changes. Iodixanol induced coronary vasodilation in subjects without CAD (8.8+/-8.6%, P<0.001). Patients with CAD exhibited no significant diameter changes in segments >/=20 mm apart from a stenosis (4.7+/-9.4%, P=NS) and significant constriction in segments <20 mm from a stenosis (-3.8+/-4.6%, P<0. 05). Similar results were obtained with iopromide, but no changes were found with ioxaglate. All contrast media induced transient (<35 seconds) increases in coronary venous oxygen saturation in all subjects. Indomethacin, but not N(G)-monomethyl-L-arginine, blunted the vasodilating effect of iodixanol and iopromide (by 80% and 76%, respectively; P<0.001).
  
  
  CONCLUSIONS
  Nonionic contrast media induce a vasodilatory response in normal vessels not by a mechanism involving increased flow or endothelial nitric oxide synthesis, but rather by depending on preserved vascular cyclooxygenase activity. CAD changes normal epicardial vasodilatory response into vasoconstriction.
authors.affiliation: Cardiac and Thoracic Department, University of Pisa, Italy. ulimbru@tin.it
authors.forename: U
authors.initials: U
authors.lastname: Limbruno
authors.forename: A S
authors.initials: AS
authors.lastname: Petronio
authors.forename: G
authors.initials: G
authors.lastname: Amoroso
authors.forename: R
authors.initials: R
authors.lastname: Baglini
authors.forename: G
authors.initials: G
authors.lastname: Paterni
authors.forename: A
authors.initials: A
authors.lastname: Merelli
authors.forename: R
authors.initials: R
authors.lastname: Mariotti
authors.lastname: Raffaele De Caterina
authors.forename: M
authors.initials: M
authors.lastname: Mariani
mesh_terms: D000368:Aged; D002317:Cardiovascular Agents / Q000494:pharmacology; D003287:Contrast Media / Q000494:pharmacology*; D017023:Coronary Angiography / Q000187:drug effects; D003326:Coronary Circulation / Q000187:drug effects; D003327:Coronary Disease / Q000378:metabolism*; D003331:Coronary Vessels / Q000187:drug effects / Q000503:physiopathology; D005119:Extravasation of Diagnostic and Therapeutic Materials; D005260:Female; D006801:Humans; D007213:Indomethacin / Q000494:pharmacology; D008297:Male; D008875:Middle Aged; D010100:Oxygen / Q000378:metabolism; D013997:Time Factors; D014283:Triiodobenzoic Acids / Q000494:pharmacology; D014666:Vasomotor System / Q000000981:diagnostic imaging / Q000187:drug effects*; D019323:omega-N-Methylarginine / Q000494:pharmacology
chemical_list: D002317:Cardiovascular Agents; D003287:Contrast Media; D014283:Triiodobenzoic Acids; D019323:omega-N-Methylarginine; C044834:iodixanol; D010100:Oxygen; D007213:Indomethacin